Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

SML3162

Sigma-Aldrich

A-1155463

≥98% (HPLC)

Synonym(s):

2-[8-[(2-Benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-5-[3-[4-[3-(dimethylamino)-1-propyn-1-yl]-2-fluorophenoxy]propyl]-4-thiazolecarboxylic acid, A 1155463

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C35H32FN5O4S2
CAS Number:
1235034-55-5
Molecular Weight:
669.79
MDL number:
MFCD29924714
UNSPSC Code:
12352200
NACRES:
NA.77

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

−20°C

SMILES string

O=C(C1=C(CN(C2=NC(C(O)=O)=C(CCCOC3=CC=C(C#CCN(C)C)C=C3F)S2)CC4)C4=CC=C1)NC5=NC6=C(S5)C=CC=C6

Biochem/physiol Actions

A-1155643 is a highly potent and highly selective BCLXL inhibitor that inhibits H146 small cell lung cancer xenograft tumor growth in mice.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Zhi-Fu Tao et al.
ACS medicinal chemistry letters, 5(10), 1088-1093 (2014-10-15)
A-1155463, a highly potent and selective BCL-XL inhibitor, was discovered through nuclear magnetic resonance (NMR) fragment screening and structure-based design. This compound is substantially more potent against BCL-XL-dependent cell lines relative to our recently reported inhibitor, WEHI-539, while possessing none
G Brent Dawe et al.
Nature communications, 10(1), 2746-2746 (2019-06-23)
Nicotinic acetylcholine receptors (nAChRs) mediate and modulate synaptic transmission throughout the brain, and contribute to learning, memory, and behavior. Dysregulation of α7-type nAChRs in neuropsychiatric as well as immunological and oncological diseases makes them attractive targets for pharmaceutical development. Recently
Anne Slomp et al.
Blood advances, 3(24), 4202-4214 (2019-12-20)
Prosurvival BCL-2 family proteins are potent inhibitors of apoptosis and often overexpressed in lymphoid malignancies. In multiple myeloma (MM), MCL-1 expression contributes to survival of malignant plasma cells, and overexpression correlates with poor prognosis. In this study, we investigated whether

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service